Environmental factors, especially microbiota, modify genetic susceptibility to many chronic diseases. The NGRRC provides an essential resource for local, regional, national and international multidisciplinary investigators to explore the hypothess that commensal bacteria strongly influence physiologic processes in normal hosts and pathogenic inflammatory, metabolic and neoplastic responses in genetically susceptible hosts. This unit provides a resource for broadly based NIH-funded investigators to examine physiologic and pathophysiologic differences in germ-free (sterile) vs. gnotobiotic (known life, selectively colonized) vs. specific pathogen-free mice of different genetic backgrounds, to explore the functional alterations of normal vs. dysbiotic bacterial communities in murine models and human diseases, and to define the functional relevance of bacterial genes. The microbiota can be precisely manipulated by colonizing germ-free rodents with single or multiple commensal or pathogenic bacterial, viral or fungal species using isogenic wild type or genetically engineered bacterial strains. In addition, fecal transplants can be performed from murine models or human donors.
Specific aims : 1. Provide germ-free or selectively colonized wild type and mutant mice or their tissues and cells to NIH-funded investigators. 2. Derive additional GF genetically engineered mouse strains for NIH-funded investigators. 3. Support pilot studies for investigators with novel hypotheses to generate preliminary data for NIH grant applications. 4. Train personnel to develop gnotobiotic facilities in other institutions, 5. Develop innovative techniques to improve our gnotobiotic resource. We provide a unique and essential resource for a multidisciplinary group of NIH-funded investigators to study the physiologic and pathophysiologic function of normal and dysbiotic commensal bacteria, with particular emphasis on gene/environmental interactions in genetically altered mice (transgenic, knockout or spontaneously mutated) with altered physiology and disease phenotypes. In the past 4 years of funding, the NGRRC provided 8930 gnotobiotic mice to 73 investigators in 46 institutions. 62 funded and 11 submitted NIH grants (in 6 Institutes) by 52 investigators depend on gnotobiotic mice from the NGRRC.

Public Health Relevance

Altered microbiota composition (dysbiosis) is associated with a number of inflammatory (IBD, NASH, atherosclerosis), metabolic (diabetes, metabolic syndrome), neoplastic (colon cancer) and even behavioral (depression, autism) disorders. However the functional consequences of these compositional changes and the role of individual bacterial species remain unknown. Selective colonization of gnotobiotic mice with native or genetically engineered bacterial species or defined consortia can determine bacterial function, host/microbial and microbial/microbial interactions.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Material Resource Grants (P40)
Project #
5P40OD010995-13
Application #
9102282
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mirochnitchenko, Oleg
Project Start
2003-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
13
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ulici, V; Kelley, K L; Azcarate-Peril, M A et al. (2018) Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice. Osteoarthritis Cartilage 26:1098-1109
Chen, Yuezhou; Chaudhary, Neha; Yang, Nicole et al. (2018) Microbial symbionts regulate the primary Ig repertoire. J Exp Med 215:1397-1415
Jacob, Noam; Jacobs, Jonathan P; Kumagai, Kotaro et al. (2018) Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Mucosal Immunol 11:1466-1476
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Schoenborn, Alexi A; von Furstenberg, Richard J; Valsaraj, Smrithi et al. (2018) The enteric microbiota regulates jejunal Paneth cell number and function without impacting intestinal stem cells. Gut Microbes :1-14
Pushalkar, Smruti; Hundeyin, Mautin; Daley, Donnele et al. (2018) The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8:403-416
Rogala, Allison R; Schoenborn, Alexi A; Fee, Brian E et al. (2018) Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice. Dis Model Mech 11:
Yan, Jing; Takakura, Ayumi; Zandi-Nejad, Kambiz et al. (2018) Mechanisms of gut microbiota-mediated bone remodeling. Gut Microbes 9:84-92
Eaton, Kathryn; Pirani, Ali; Snitkin, Evan S et al. (2018) Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 7:
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6

Showing the most recent 10 out of 89 publications